Literature DB >> 22308070

Helicobacter pylori Infection and Inflammation: Implication for the Pathophysiology of Diabetes and Coronary Heart Disease in Asian Indians.

M Afzalur Rahman1, Mark B Cope, Shafique A Sarker, W Timothy Garvey, Habib S Chaudhury, Mohammad A Khaled.   

Abstract

Asian Indians living in the Indian subcontinent or abroad experience high rate of coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Asian Indians are also known to suffer from various infections, particularly during their childhood. One such chronic infection is with Helicobacter pylori (H. pylori). Since H. pylori with its specific virulence factor cytotoxin-associated gene A (cagA) has been suggested to be associated with CHD, a role of this H. pylori infection was investigated in the pathogenesis of CHD in Asian Indians living in Bangladesh. H. pylori (CagA) infected subjects with CHD (HP+ve cases, n=21), and without CHD (HP+ve controls, n=20), and non-infected without CHD (HP-ve normal controls, n=21) were included in this study. Thromboxane (TXB), an index of platelet activation, was found to be significantly higher in the HP+ve cases (p=0.05), but not in the HP+ve controls (p=0.88) when compared with HP-ve controls. Analyses of lipid profiles revealed that while triglycerides, total cholesterol and LDL did not show any significant changes, HDL was significantly lower in both the HP+ve cases (p=0.0003) and controls (p=0.005). The mean fasting glucose level in the HP+ve cases was markedly increased (p>0.0001), while it was intermediate in the HP+ve controls, and lowest in the HP-ve controls. HOMA-IR values, a measure of insulin resistance, did not reflect any substantial differences between the HP+ve and HP-ve controls, but they were highly significantly different between the HP+ve cases and HP-ve controls. HOMA-B, indicating insulin secretory dysfunction (ISD), was significantly higher in both the HP+ve groups when compared with the normal controls. The data indicate that H. pylori infection is associated with impaired insulin secretion, and that a component of insulin resistance that occurs independent of H. pylori can then lead to a worsening of glucose tolerance and the development of CHD. This is the first demonstration to our knowledge that H. pylori (CagA) infection is associated with insulin secretory dysfunction in human subjects. Since many Asian Indians contract various other chronic and acute infections, it is important to investigate the role of H. pylori and other infectious agents in the pathogenesis of T2DM and CHD.

Entities:  

Year:  2009        PMID: 22308070      PMCID: PMC3269913          DOI: 10.1080/09751270.2009.11885133

Source DB:  PubMed          Journal:  J Life Sci        ISSN: 1229-1552


  25 in total

1.  Hyperhomocysteinemia due to Helicobacter pylori?

Authors:  Mohammad A Khaled; Phillip E Cornwell
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

Review 2.  Cyclooxygenase inhibition and cardiovascular risk.

Authors:  Elliott M Antman; David DeMets; Joseph Loscalzo
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

3.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

4.  The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology.

Authors:  E D Janus; A Postiglione; R B Singh; B Lewis
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

5.  Phospholipases A2 in gastric juice of Helicobacter pylori--positive and negative individuals.

Authors:  H T Huhtinen; J M Grönroos; M M Haapamäki; T J Nevalainen
Journal:  Clin Chem Lab Med       Date:  1999-01       Impact factor: 3.694

Review 6.  Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness.

Authors:  J M Fernández-Real; W Ricart
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

7.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

Review 8.  Helicobacter pylori and gastric acid: biological and therapeutic implications.

Authors:  C C McGowan; T L Cover; M J Blaser
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.

Authors:  P M McKeigue; B Shah; M G Marmot
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

View more
  10 in total

1.  Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study.

Authors:  C-Y Lai; T-Y Yang; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-26       Impact factor: 3.267

Review 2.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  Is helicobacter pylori infection a risk factor for coronary heart disease?

Authors:  Mehran Rogha; Marjan Nikvarz; Zahra Pourmoghaddas; Keivan Shirneshan; Davood Dadkhah; Masoud Pourmoghaddas
Journal:  ARYA Atheroscler       Date:  2012

4.  Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?

Authors:  Jamshid Vafaeimanesh; Mahmoud Parham; Mohammad Bagherzadeh
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

5.  Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease.

Authors:  Anita Jukic; Dorotea Bozic; Dusko Kardum; Tina Becic; Bruno Luksic; Mislav Vrsalovic; Marko Ljubkovic; Damir Fabijanic
Journal:  Ther Clin Risk Manag       Date:  2017-07-27       Impact factor: 2.423

6.  Helicobacter pylori increases the risk of carotid plaque formation: a clinical evidence.

Authors:  Haiqing Liang; Shuzhu Lin; Yongjian Ji; Yang Xiao; Guifang Zheng
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 7.  Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems.

Authors:  Li Wang; Zheng-Min Cao; Li-Li Zhang; Xin-Can Dai; Zhen-Ju Liu; Yi-Xian Zeng; Xin-Ye Li; Qing-Juan Wu; Wen-Liang Lv
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

8.  Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a Sub-Saharan setting.

Authors:  Lionel Danny Nguefak Tali; Ghislaine Florice Nintewoue Faujo; Justine Laure Nguieguia Konang; Jean Paul Dzoyem; Laure Brigitte Mabeku Kouitcheu
Journal:  BMC Infect Dis       Date:  2022-09-12       Impact factor: 3.667

9.  Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor?

Authors:  Jamshid Vafaeimanesh; Seyyed Fakhroldin Hejazi; Vahid Damanpak; Mostafa Vahedian; Mohammadamin Sattari; Mohammadreza Seyyedmajidi
Journal:  ScientificWorldJournal       Date:  2014-01-16

Review 10.  The Association between Helicobacter pylori Infection and Glycated Hemoglobin A in Diabetes: A Meta-Analysis.

Authors:  Jinhu Chen; Yuling Xing; Liying Zhao; Huijuan Ma
Journal:  J Diabetes Res       Date:  2019-09-09       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.